Paul M. McNicholas

2.9k total citations
43 papers, 2.3k citations indexed

About

Paul M. McNicholas is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Paul M. McNicholas has authored 43 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 16 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Paul M. McNicholas's work include Antifungal resistance and susceptibility (18 papers), Bacterial Genetics and Biotechnology (14 papers) and Fungal Infections and Studies (9 papers). Paul M. McNicholas is often cited by papers focused on Antifungal resistance and susceptibility (18 papers), Bacterial Genetics and Biotechnology (14 papers) and Fungal Infections and Studies (9 papers). Paul M. McNicholas collaborates with scholars based in United States, Hungary and Germany. Paul M. McNicholas's co-authors include David Loebenberg, Cara Mendrick, Andrew S. Chau, Paul A. Mann, R S Hare, Todd A. Black, F. Sabatelli, Robert P. Gunsalus, Donald Oliver and Robert E. Palermo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Molecular Biology.

In The Last Decade

Paul M. McNicholas

43 papers receiving 2.3k citations

Peers

Countries citing papers authored by Paul M. McNicholas

Since Specialization

Citations

This map shows the geographic impact of Paul M. McNicholas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. McNicholas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. McNicholas more than expected).

Fields of papers citing papers by Paul M. McNicholas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. McNicholas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. McNicholas. The network helps show where Paul M. McNicholas may publish in the future.

Co-authorship network of co-authors of Paul M. McNicholas

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. McNicholas. A scholar is included among the top collaborators of Paul M. McNicholas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. McNicholas. Paul M. McNicholas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of HIV-1 CXCR4 tropism and resistance in treatment experienced subjects receiving CCR5 antagonist—Vicriviroc 2012 ·Journal of Clinical Virology ·Paul M. McNicholas, Regis A. Vilchez, Wayne Greaves, Sushma Kumar, (unknown), Todd A. Black, Julie Strizki	4
2	The optimization of pyridazinone series of glucan synthase inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Rongze Kuang, He‐Ping Wu, Pauline C. Ting, Robert Aslanian, Jianhua Cao, David W. Kim, (unknown), (unknown), (unknown), R. Jason Herr, (unknown), (unknown), (unknown), David M. Jenkins, (unknown), Samuel B. Wainhaus, Todd A. Black, Anthony Cacciapuoti, Paul M. McNicholas, Yiming Xu, Scott S. Walker	8
3	Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), David M. Jenkins, R. Jason Herr, Pauline C. Ting, (unknown), Rongze Kuang, He‐Ping Wu, David W. Kim, Robert Aslanian, Samuel B. Wainhaus, Todd A. Black, Anthony Cacciapuoti, Paul M. McNicholas, Yiming Xu, Scott S. Walker	7
4	Mapping and Characterization of Vicriviroc Resistance Mutations From HIV-1 Isolated from Treatment-Experienced Subjects Enrolled in a Phase II Study (VICTOR-E1) 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Paul M. McNicholas, Paul A. Mann, (unknown), Ping Qiu, Erin Lee, Michael J. McCarthy, (unknown), Todd A. Black, Julie Strizki	20
5	The synthesis and structure–activity relationship of pyridazinones as glucan synthase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Pauline C. Ting, Rongze Kuang, He‐Ping Wu, Robert Aslanian, Jianhua Cao, David W. Kim, (unknown), (unknown), (unknown), Samuel B. Wainhaus, Todd A. Black, Anthony Cacciapuoti, Paul M. McNicholas, Yiming Xu, Scott S. Walker	16
6	SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Pauline C. Ting, Robert Aslanian, Jianhua Cao, David W. Kim, Rongze Kuang, (unknown), (unknown), He‐Ping Wu, R. Jason Herr, (unknown), (unknown), (unknown), Samuel B. Wainhaus, Todd A. Black, Paul M. McNicholas, Yiming Xu, Scott S. Walker	30
7	Characterization of Emergent HIV Resistance in Treatment‐Naive Subjects Enrolled in a Vicriviroc Phase 2 Trial 2010 ·The Journal of Infectious Diseases ·Paul M. McNicholas, Yi Wei, Jeannette M. Whitcomb, Wayne Greaves, Todd A. Black, Cécile Tremblay, Julie Strizki	25
8	Design and synthesis of potent Gram-negative specific LpxC inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Umar Faruk Mansoor, Dilrukshi Vitharana, (unknown), Dayna L. Daubaras, Paul M. McNicholas, Peter Orth, Todd A. Black, M. Arshad Siddiqui	36
9	Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species 2009 ·Antimicrobial Agents and Chemotherapy ·Paul A. Mann, Paul M. McNicholas, Andrew S. Chau, Reena Patel, Cara Mendrick, Andrew J. Ullmann, Oliver A. Cornely, Hernando Patino, Todd A. Black	64
10	Comparativein vitroactivities of posaconazole, voriconazole, itraconazole, and amphotericin B againstAspergillusandRhizopus, and synergy testing forRhizopus 2008 ·Medical Mycology ·Sevtap Arıkan, Banu Sancak, Şehnaz Alp, Gülşen Hasçelik, Paul M. McNicholas	53
11	Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species 2007 ·Journal of Antimicrobial Chemotherapy ·(unknown), Gábor Kardos, Paul M. McNicholas, Enikő Balogh, Lajos Gergely, Ivan Varga, (unknown), László Majoros	29
12	In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts 2006 ·Antimicrobial Agents and Chemotherapy ·F. Sabatelli, Rutul Patel, Paul A. Mann, Cara Mendrick, Christine Norris, R S Hare, David Loebenberg, Todd A. Black, Paul M. McNicholas	377
13	Expression of the heme biosynthetic pathway genes hemCD, hemH, hemM and hemA of Escherichia coli 2006 ·FEMS Microbiology Letters ·Paul M. McNicholas, George T. Javor, (unknown), Robert P. Gunsalus	19
14	Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections 2005 ·Journal of Antimicrobial Chemotherapy ·(unknown), Guillermo Quindós, (unknown), (unknown), (unknown), (unknown), Paul M. McNicholas, David Loebenberg, (unknown)	24
15	Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles 2004 ·Antimicrobial Agents and Chemotherapy ·Andrew S. Chau, Cara Mendrick, F. Sabatelli, David Loebenberg, Paul M. McNicholas	154
16	Anaerobic regulation of the Escherichia coli dmsABC operon requires the molybdate‐responsive regulator ModE 1998 ·Molecular Microbiology ·Paul M. McNicholas, (unknown), Robert P. Gunsalus	50
17	Characterization of the ModE DNA‐binding sites in the control regions of modABCD and moaABCDE of Escherichia coli 1997 ·Molecular Microbiology ·Paul M. McNicholas, Sabine Rech, Robert P. Gunsalus	49
18	Dual regulation of Escherichia coli secA translation by distinct upstream elements 1997 ·Journal of Molecular Biology ·Paul M. McNicholas, Reza Salavati, Donald Oliver	40
19	The Escherichia coli modE gene: effect of modE mutations on molybdate dependent modA expression 1996 ·FEMS Microbiology Letters ·Paul M. McNicholas	15
20	The tet(K) gene from Staphylococcus aureus mediates the transport of potassium in Escherichia coli 1993 ·Journal of Bacteriology ·(unknown), Margareta Tuckman, Paul M. McNicholas, David M. Rothstein	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact